
|Videos|March 8, 2022
Dr. Rogers discusses FDA approval of InterStim X system
Author(s)Urology Times staff
The device is indicated for overactive bladder, chronic fecal incontinence, and non-obstructive urinary retention.
Advertisement
In this video, Alexandra Rogers, MD, comments on the recent FDA approval of the InterStim X system. Rogers is a urologist in Boulder, Colorado.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones
2
Practical guide to female pelvic organ–sparing radical cystectomy
3
CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction
4
Targeting BCG resistance in high-risk NMIBC
5






